Posted by Michael Wonder on 14 Feb 2022
Medscape awarded contract from FDA to develop educational programming focused on biosimilars
14 February 2022 - Medscape Education has been awarded a contract from the U.S. FDA for the development of an educational curriculum and outreach programs on the use of biosimilars in medical practice.
Created to enhance health care providers' understanding of biosimilars, the program will include accredited continuing education courses for physicians, pharmacists, and nurses, covering a broad range of topics on biosimilars.
